declined after accelerating in the previous quarter. Looking forward, financial institutions expect demand for business credit to increase, especially for large corporates to invest in fixed assets for
30.8 percent increase from last year, due to the recognition of special profits from the sale of investments. At the end of 2019, loan growth in the Thai commercial banking system decreased to 2.0
standard, resulting to the increase of interest expense from the same quarter of the previous year. In this quarter, the Company had no amount of share of profit from investments in associates but recorded
Capital (Increase capital 450 million on 29 November-2018) 300.00 Shareholders- Equity 215.48 Total Revenue 34.96 Expenditure 64.83 Net Profit (Loss) (29.87) Earning Per Share (E.P.S.) (0.27) Book value per
tax expenses -5.80 -4.89 0.91 19% Net income for period 24.74 23.17 1.57 7% Earnings per share (THB) 0.08 0.08 0.00 0% FY 2018 FY 2017 YoY change YoY % change Unit: Million Thai Baht (THB) Sales and
2022 % 2021 % Increase (Decrease) % Revenue from sales and services 2,351.40 100.00% 1,455.25 100.00% 896.15 61.58% Cost of sales and services 2,208.18 93.91% 1,319.00 90.64% 889.18 67.41% Gross profit
2,097.62 1,600.35 Selling & Administrative Expense 127.83 116.99 Finance Costs 24.24 22.96 Net Profit 101.40 (18.95) Earnings per share (Baht) 0.25 (0.047) The company will explain the cause of change as
statements for the 2nd quarter of year 2017 ended June30,2017. The details are as follows: 1. For the 2nd quarter of year 2017, total revenues from sales were 424.64 million Baht, or an increase of 3.23% from
last year and total revenues of 1,579.40 million Baht which also increased 7.6% from last year. This was due to increase in aluminium price. 2. Cost of sales was 1,463.45 million Baht or at 93.65% of
when compared to income from medical treatments went up 0.86%. due to expending employment increase to accommodate the number of patients is increasing. The cost of selling and administrative when